Search
The Newsletter
The Principals
Reports
Conferences
Physician Surveys
Consulting
Contact Us
 
Home
 


Online Report Subscribers, Click Here
Pricing and Ordering Information

U.S. Markets for Percutaneous Transluminal Coronary Angioplasty and Coronary Stent Products
March 2002, 224 pages
Report #RP-891411

Despite major technology-driven advances in the management of coronary artery disease, more than 450,000 people die from the condition in the United States each year.  The morbidity and mortality associated with the disease continue to fuel the demand for products used to treat advanced cases that cannot be adequately managed via medical therapy.  In the 21st century, percutaneous intervention is considered the coronary artery disease treatment of choice, with annual sales of percutaneous transluminal coronary angioplasty and coronary stenting products exceeding $2.4 billion.

This report from Medtech Insight includes analyses of technologies, products, current and forecast markets, competitors, and opportunities in the percutaneous transluminal coronary angioplasty and coronary stenting products market.

Major topics include:  balloon & guiding catheters; coronary stent materials & designs; coronary stent restenosis treatment systems; coronary stenting applications & approaches; guidewires & sheath introducers; inflation & arterial access closure devices; managed care, third-party payers & reimbursement; transcatheter techniques; and vulnerable plaque detection & treatment.

Methodology

Reports are produced exclusively by Medtech Insight, through extensive primary and secondary research among the clinicians, researchers, and competitors in the marketplace, and draw upon the industry expertise of a network of industry insiders. Medtech Insight exhaustively corroborates the data as a baseline for completing forward-looking analysis and providing insight into product, technology and market evolution.

 

TABLE OF CONTENTS

 

EXECUTIVE SUMMARY

     i.    Evolution of Coronary Artery Disease Management

ii.    Percutaneous Transluminal Coronary Angioplasty and Coronary
  Stenting Products Market

     iii.   Percutaneous Transluminal Coronary Angioplasty Balloon
           Catheters

     iv.  Coronary Guiding Catheters

     v.   Coronary Guidewires

     vi.  Introducer Sheaths

vii.  Percutaneous Transluminal Coronary Angioplasty/Coronary
 Stenting Inflation Devices

     viii. Arterial Access Closure Devices

     ix.  Coronary Stent Systems

     x.   Intravascular Brachytherapy Systems

     xi.   Report Methodology

 

1. OVERVIEW OF CORONARY ARTERY DISEASE MANAGEMENT

     1.1 Coronary Artery Disease

          1.1.1 Types

                  1.1.1.1 Atherosclerosis

                             1.1.1.1.1 Etiology and Symptomology

                             1.1.1.1.2 Incidence and Prevalence

                  1.1.1.2 Angina Pectoris

                             1.1.1.2.1 Etiology and Symptomology

                             1.1.1.2.2 Incidence and Prevalence

                  1.1.1.3 Myocardial Infarction

                             1.1.1.3.1 Etiology and Symptomology

                             1.1.1.3.2 Incidence and Prevalence

          1.1.2 Disease Management

                  1.1.2.1 Medical Management

                             1.1.2.1.1 Lifestyle Changes

                             1.1.2.1.2 Pharmaceuticals

                  1.1.2.2 Surgical Intervention

                             1.1.2.2.1 Coronary Artery Bypass Grafting

                             1.1.2.2.2 Transmyocardial Revascularization

                  1.1.2.3 Selected Transcatheter Techniques

                             1.1.2.3.1 Percutaneous Transluminal Coronary
                                          Angioplasty

                             1.1.2.3.2 Coronary Stenting

                             1.1.2.3.3 Other Transcatheter Methods

 1.1.2.3.3.1 Vulnerable Plaque
                 Identification

 

2.   PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY PRODUCTS MARKET

     2.1 Percutaneous Transluminal Coronary Angioplasty

          2.1.1 Approaches

          2.1.2 Applications

          2.1.3 Efficacy

                  2.1.3.1 Complications

                  2.1.3.2 Outcomes

          2.1.4 Anti-Clotting Drug Effects

          2.1.5 Restenosis

          2.1.6 Costs

          2.1.7 Procedure Volumes

     2.2 Percutaneous Transluminal Coronary Angioplasty Products

          2.2.1 Balloon Catheters

                  2.2.1.1 Market Forecast

                  2.2.1.2 Competitive Analysis

          2.2.2 Guiding Catheters

                  2.2.2.1 Market Forecast

                  2.2.2.2 Competitive Analysis

          2.2.3 Guidewires

                  2.2.3.1 Market Forecast

                  2.2.3.2 Competitive Analysis

          2.2.4 Introducer Sheaths

                  2.2.4.1 Market Forecast

                  2.2.4.2 Competitive Analysis

          2.2.5 Inflation Devices

                  2.2.5.1 Market Forecast

                  2.2.5.2 Competitive Analysis

          2.2.6 Arterial Access Closure Devices

                  2.2.6.1 Market Forecast

                  2.2.6.2 Competitive Analysis

2.3 Technological Developments in Percutaneous Transluminal
 Coronary Angioplasty

          2.3.1 Embolic Protection Devices

                  2.3.1.1 Distal Filter Devices

                  2.3.1.2 Distal Balloon Occlusion Devices

                  2.3.1.3 Proximal Balloon Occlusion Devices

                  2.3.1.4 Market Analysis

          2.3.2 Other Areas of Technological Development

 

3. CORONARY STENT PRODUCTS MARKET

     3.1 Types of Coronary Stents

          3.1.1 Materials

                  3.1.1.1 Stainless Steel

                  3.1.1.2 Nitinol

                  3.1.1.3 Tantalum

                  3.1.1.4 Other Materials

          3.1.2 Coatings

                  3.1.2.1 Coated Stents

                  3.1.2.2 Drug-Eluting Stents

                  3.1.2.3 Covered Stents

          3.1.3 Designs

                  3.1.3.1 Mesh

                  3.1.3.2 Coil

                  3.1.3.3 Slotted-Tube

                  3.1.3.4 Other Configurations

          3.1.4 Diameters

          3.1.5 Radiopacity

     3.2 Coronary Stenting Applications and Approaches

          3.2.1 Stent Delivery

          3.2.2 Stent Deployment

          3.2.3 Efficacy

                  3.2.3.1 Clinical Studies

                  3.2.3.2 Outcomes

          3.2.4 Complications

          3.2.5 Restenosis

          3.2.6 Costs

          3.2.7 Procedure Volumes

     3.3 Coronary Stent Products

          3.3.1 Pricing Trends

          3.3.2 Market Forecast

          3.3.3 Competitive Analysis

     3.4 Coronary Stent Restenosis Treatment Systems

          3.4.1 Pricing Trends

          3.4.2 Market Forecast

          3.4.3 Competitive Analysis

 

4.   GENERAL ISSUES IN PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY AND CORONARY STENTING

     4.1 Managed Care, Third-Party Payers, and Reimbursement

     4.2 Regulatory Concerns

     4.3 Group Purchasing Organizations

 

5. COMPANY PROFILES

     5.1   Biocompatibles International PLC

     5.2   Boston Scientific Corporation

     5.3   Cook, Inc./Cook Group

     5.4   Cordis Corporation/Johnson & Johnson

     5.5   Guidant Corporation

     5.6   JOMED NV

     5.7   Kensey Nash Corporation

     5.8   Perclose/Abbott Laboratories

     5.9   PharmaSonics, Inc.

     5.10 Medtronic, Inc.

     5.11 Merit Medical Systems, Inc.

     5.12 Microvena Corporation

     5.13 Novoste Corporation

     5.14 Radiance Medical Systems, Inc.

     5.15 St. Jude Medical, Inc.

     5.16 SurModics, Inc.

 

COMPANY LISTING

LIST OF EXHIBITS

 

Exhibit ES-1:   Ischemic Heart Disease Diagnoses for Patients Discharged from Acute Care Hospitals, 1995-1999 

Exhibit ES-2:   Percutaneous Transluminal Coronary Angioplasty and Coronary Stent Implantations, Historic and Forecast Procedure Volumes, 1993-2006 

Exhibit ES-3:   Percutaneous Transluminal Coronary Angioplasty and Coronary Stent Products, Market Forecast, 2000-2006 

Exhibit ES-4:   Percutaneous Transluminal Coronary Angioplasty Balloon Catheters, Market Forecast, 2000-2006 

Exhibit ES-5:   Coronary Guiding Catheters, Market Forecast, 2000-2006 

Exhibit ES-6:   Coronary Guidewires, Market Forecast, 2000-2006 

Exhibit ES-7:   Introducer Sheaths, Market Forecast, 2000-2006 

Exhibit ES-8:   Percutaneous Transluminal Coronary Angioplasty/
Stenting Inflation Devices, Market Forecast, 2000-2006

Exhibit ES-9:   Arterial Access Closure Devices, Market Forecast, 2000-2006 

Exhibit ES-10:  Coronary Stent Systems, Market Forecast, 2000-2006 

Exhibit ES-11:  Intravascular Brachytherapy Systems, Market Forecast, 2000-2006 

 

Exhibit 1-1:     Prevalence Figures for Selected Forms of Cardiovascular Disease in the United States 

Exhibit 1-2:     Ischemic Heart Disease Diagnoses for Patients Discharged from Acute Care Hospitals, 1995-1999 

Exhibit 1-3:     Coronary Atherosclerosis Diagnoses in Discharged Hospital Patients, 1995-1999 

Exhibit 1-4:     Standard Angina Pectoris Classification 

Exhibit 1-5:     2001, Low-Density Lipoprotein Cholesterol, Target and Drug Therapy Initiation Levels 

Exhibit 1-6:     Coronary Artery Bypass Grafting, Inpatient Discharges, 1985-1999 

Exhibit 1-7:     2001, Selected Vulnerable Plaque Detection Technologies in Development 

 

Exhibit 2-1:     Complications Associated with the Performance of Percutaneous Transluminal Coronary Angioplasty 

Exhibit 2-2:     Post-Percutaneous Transluminal Coronary Angioplasty Target Vessel Revascularization Rates 

Exhibit 2-3:     Costs Associated with Percutaneous Transluminal Coronary Angioplasty 

Exhibit 2-4:     2001, Estimated Consumables Cost per Percutaneous Transluminal Coronary Angioplasty Procedure 

Exhibit 2-5:     Percutaneous Transluminal Coronary Angioplasty, Historic Procedure Volumes, 1985-1999 

Exhibit 2-6:     Percutaneous Transluminal Coronary Angioplasty, Combined Inpatient and Outpatient Procedure Volumes, 1985-2001 

Exhibit 2-7:     Types of Percutaneous Transluminal Coronary Angioplasty Balloon Catheters 

Exhibit 2-8:     2001, Selected Percutaneous Transluminal Coronary Angioplasty Balloon Catheters 

Exhibit 2-9:     Percutaneous Transluminal Coronary Angioplasty Balloon Catheters, Market Forecast, 2000-2006 

Exhibit 2-10:   2000, Percutaneous Transluminal Coronary Angioplasty Balloon Catheters Market, Share by Supplier 

Exhibit 2-11:   2002, Selected Coronary Guiding Catheters 

Exhibit 2-12:   Coronary Guiding Catheters, Market Forecast, 2000-2006 

Exhibit 2-13:   2000, Coronary Guiding Catheters Market, Share by Supplier 

Exhibit 2-14:   2002, Selected Coronary Guidewires 

Exhibit 2-15:   Coronary Guidewires, Market Forecast, 2000-2006 

Exhibit 2-16:   2000, Coronary Guidewires Market, Share by Supplier 

Exhibit 2-17:   2001, Selected Introducer Sheaths 

Exhibit 2-18:   Introducer Sheaths, Market Forecast, 2000-2006 

Exhibit 2-19:   2000, Introducer Sheaths Market, Share by Supplier 

Exhibit 2-20:   2002, Selected Percutaneous Transluminal Coronary Angioplasty/Stenting Inflation Devices 

Exhibit 2-21:   Percutaneous Transluminal Coronary Angioplasty/
Stenting Inflation Devices, Market Forecast, 2000-2006

Exhibit 2-22:   2000, Percutaneous Transluminal Coronary Angioplasty/ Stenting Inflation Devices Market, Share by Supplier 

Exhibit 2-23:   2002, Selected Arterial Access Closure Devices 

Exhibit 2-24:   Arterial Access Closure Devices, Market Forecast, 2000-2006 

Exhibit 2-25:   2000, Arterial Access Closure Devices, Share by Supplier 

Exhibit 2-26:   Comparison of Embolic Protection Device Designs 

 

Exhibit 3-1:     Costs Associated with Coronary Stenting 

Exhibit 3-2:     2001, Estimated Consumables Cost per Coronary Stenting Procedure 

Exhibit 3-3:     Coronary Stent Implantations, Historic and Forecast Procedure Volumes, 1993-2006 

Exhibit 3-4:     2002, Selected Coronary Stent Systems 

Exhibit 3-5:     Coronary Stent Systems, Market Forecast, 2000-2006 

Exhibit 3-6:     2000, Coronary Stent Systems Market, Share by Supplier 

Exhibit 3-7:     2002, Selected Restenosis Treatment Products and Technologies 

Exhibit 3-8:     Intravascular Brachytherapy Systems, Market Forecast, 2000-2006 

Exhibit 3-9:     2001, Intravascular Brachytherapy Systems Market, Share by Supplier 

 

Exhibit 4-1:     Projected Growth in Medicare/Medicaid Spending Versus Gross Domestic Product 

 

Copyright 2002, Medtech Insight, LLC

 


Ordering Information

 

Title

Report#

Publication
Date

List Price

U.S. Markets for Percutaneous Transluminal Coronary Angioplasty and Coronary Stent Products

RP-891411

March
2002

$3,950*

 

*The pdf version of each report costs an additional $500 when purchased in addition to the hardcopy.

 

To order reports or obtain information about special pre-publication offers from within the U.S., contact reports@medtechinsight.com. From outside the U.S., contact internationalsales@medtechinsight.com. You can also call 1.949.219.0150 (or toll-free within the U.S. at 1.888.290.2225) or fax 1.949.219.0037.

 

The Newsletter | The Principals | Reports | Conferences | Physician Surveys | Consulting | Contact Us | Home